Aardvark therapeutics to present data on pipeline programs at upcoming obesityweek

San diego, oct. 22, 2025 (globe newswire) -- aardvark therapeutics, inc. (aardvark) (nasdaq: aard), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, announced that it will present poster presentations at obesityweek 2025, which is being held on november 4-7, 2025 in atlanta, georgia. obesityweek presentation details: title: tas2r pan-agonist ard-101 attenuates weight gain in mice and reduces hunger in adults with obesity date and time: tuesday, november 4, 2025 at 7:30 p.m.
AARD Ratings Summary
AARD Quant Ranking